# Lipoic Acid Supplement for Cystine Stone

> **NCT02910531** · PHASE2 · COMPLETED · sponsor: **Thomas Chi, MD** · enrollment: 50 (actual)

## Conditions studied

- Cystinuria

## Interventions

- **DIETARY_SUPPLEMENT:** Alpha lipoic acid
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02910531
- **Lead sponsor:** Thomas Chi, MD
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-06-19
- **Primary completion:** 2024-12-18
- **Final completion:** 2024-12-18
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2026-04-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02910531

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02910531, "Lipoic Acid Supplement for Cystine Stone". Retrieved via AI Analytics 2026-07-16 from https://api.ai-analytics.org/clinical/NCT02910531. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*